Founded in 2009, Bentley InnoMed develops, manufactures, and markets innovative devices for endovascular treatments. Its focus lies on covered balloon-expandable stents used notably to treat peripheral arterial disease and abdominal aortic aneurysms.
Bentley InnoMed benefits from a global reach, with its products sold in 80+ countries across the globe. They offer the widest portfolio of covered balloon-expandable stents in the market and one of their devices, a catheter for chronic total occlusion treatment, is already FDA-approved in the U.S.
Bentley InnoMed is headquartered in Stockholm, Sweden, and totals c.400 highly qualified employees.
Location: Germany, Baden-Württemberg, Hechingen